- Issuer ticker
-
APLS
- Reported as of
-
20 Jan 2023
- Net transaction value
-
-$123,827
- SEC form
-
4
- Accepted by SEC
-
24 Jan 2023, 16:23:54 UTC
Filing notes and source
Key filing fact
Timothy Eugene Sullivan filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 24 Jan 2023.
Key facts
- This page summarizes Timothy Eugene Sullivan's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jan 2023, 16:23.
Change
- Previous filing in this sequence was filed on 17 Jan 2023.
- Current net transaction value: -$123,827.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLS
transaction
Common Stock
Tax liability
- Transaction value
- -$123,827
- Shares
- -2,379
- Change %
- -1.9%
- Price
-
$52.05
- Shares after
- 124,762
- Date
- 20 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote